BIO-TECHNE Corp 4
4 · BIO-TECHNE Corp · Filed May 10, 2016
Insider Transaction Report
Form 4
BIO-TECHNE CorpTECH
Dinarello Charles A
Director
Transactions
- Sale
Common Stock
2016-05-09$101.91/sh−5,000$509,550→ 6,559 total
Holdings
- 4,000
Stock Options (Right to Buy)
Exercise: $87.39From: 2013-10-31Exp: 2023-10-30→ Common Stock (4,000 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $65.47From: 2008-10-23Exp: 2018-10-22→ Common Stock (5,000 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $63.03From: 2009-10-29Exp: 2019-10-28→ Common Stock (5,000 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $61.46From: 2010-10-28Exp: 2020-10-27→ Common Stock (5,000 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $70.35From: 2011-10-27Exp: 2021-10-26→ Common Stock (5,000 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $66.59From: 2007-10-25Exp: 2017-10-24→ Common Stock (5,000 underlying) - 4,000
Stock Options (Right to Buy)
Exercise: $91.78From: 2014-10-30Exp: 2024-10-30→ Common Stock (4,000 underlying) - 4,260
Stock Options (Right to Buy)
Exercise: $87.34From: 2016-10-29Exp: 2025-10-28→ Common Stock (4,260 underlying) - 5,000
Stock Options (Right to Buy)
Exercise: $66.90From: 2012-10-25Exp: 2022-10-24→ CommonS tock (5,000 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.85 to $102.01, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.